IHC of Epstein Barr Virus on an FFPE Hodgkin’s Lymphoma Tissue
|Intended Use||Analyte Specific Reagent: analytical and performance characteristics are not established|
|Summary and Explanation||
The Epstein-Barr virus (EBV), also called Human Herpesvirus 4 (HHV-4), is a virus of the Herpes family, and is one of the most common viruses in humans. The virus can execute many distinct programs of gene expression, which can be broadly categorized as being lytic cycle or latent cycle. The lytic cycle, or productive infection, results in staged expression of several viral proteins with the ultimate objective of producing infectious virions. The latent cycle (lysogenic) programs are those that do not result in production of virions. A very limited, distinct set of viral proteins are produced during latent cycle infection. These include Epstein-Barr nuclear antigens EBNA-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C, EBNA-leader protein (EBNA-LP), latent membrane proteins LMP-1, LMP-2A and LMP-2B and the Epstein-Barr encoded RNAs (EBERs). In addition, EBV codes for at least twenty microRNAs which are expressed in latently infected cells.
|Antibody Type||Mouse Monoclonal||Clone||CS1-4|
|Localization||Cytoplasmic||Control||EBV Infected Tissue, Hodgkin’s Lymphoma|
|Presentation||Uroplakin III is a rabbit monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.|
|Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.|